Cargando…
Identification of FtfL as a novel target of berberine in intestinal bacteria
BACKGROUND: Berberine (BBR) is a commonly used anti-intestinal inflammation drug, and its anti-cancer activity has been found recently. BBR can intervene and control malignant colorectal cancer (CRC) through intestinal microbes, but the direct molecular target and related mechanism are unclear. This...
Autores principales: | Yan, Jinci, Fang, Chengli, Yang, Gaohua, Li, Jianxu, Liu, Yanqiang, Zhang, Lu, Yang, Pengjie, Fang, Jingyuan, Gu, Yang, Zhang, Yu, Jiang, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696740/ https://www.ncbi.nlm.nih.gov/pubmed/38049785 http://dx.doi.org/10.1186/s12915-023-01778-w |
Ejemplares similares
-
Discovery of an ene-reductase for initiating flavone and flavonol catabolism in gut bacteria
por: Yang, Gaohua, et al.
Publicado: (2021) -
The FTF gene family regulates virulence and expression of SIX effectors in Fusarium oxysporum
por: Niño‐Sánchez, Jonathan, et al.
Publicado: (2016) -
Chemopreventive effects of berberine on intestinal tumor development in Apc(min/+) mice
por: Cao, Hailong, et al.
Publicado: (2013) -
Tartary buckwheat FtF3′H1 as a metabolic branch switch to increase anthocyanin content in transgenic plant
por: Li, Chenglei, et al.
Publicado: (2022) -
Interactive Regulation of Formate Dehydrogenase during CO(2) Fixation in Gas-Fermenting Bacteria
por: Zhang, Lu, et al.
Publicado: (2020)